Ahmed S, Karim MM, Ross AG, Hossain MS, Clemens JD, Sumiya MK, Phru CS, Rahman M, Zaman K, Somani J, Yasmin R, Hasnat MA, Kabir A, Aziz AB, Khan WA (2021) A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int J Infect Dis 103:214–216. https://doi.org/10.1016/j.ijid.2020.11.191
Article CAS PubMed Google Scholar
Ali BH (1990) The effect of ivermectin on some haematological indices in rabbits: influence of vitamin K treatment. Clin Exp Pharmacol Physiol 17(10):735–738. https://doi.org/10.1111/j.1440-1681.1990.tb01273.x
Article CAS PubMed Google Scholar
Andries M, Van Damme P, Robberecht W, Van Den Bosch L (2007) Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 25(1):8–16. https://doi.org/10.1016/j.nbd.2006.08.018
Article CAS PubMed Google Scholar
Aryannejad A, Tabary M, Noroozi N, Mashinchi B, Iranshahi S, Tavangar SM, Mohammad Jafari R, Rashidian A, Dehpour AR (2022) Anti-inflammatory Effects of Ivermectin in the Treatment of Acetic Acid-Induced Colitis in Rats: Involvement of GABA B Receptors. Dig Dis Sci 67(8):3672–3682. https://doi.org/10.1007/s10620-021-07258-x
Article CAS PubMed Google Scholar
Attar A, Liu T, Chan W-TC, Hayes J, Nejad M, Lei K, Bitan G (2013) A shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer’s disease. PLoS One 8(11):e80355. https://doi.org/10.1371/journal.pone.0080355
Article CAS PubMed PubMed Central Google Scholar
Babataheri S, Malekinejad H, Mosarrezaii A, Soraya H (2023) Pre-treatment or post-treatment with hydroxychloroquine demonstrates neuroprotective effects in cerebral ischemia/reperfusion. Fundam Clin Pharmacol 37(3):589–598. https://doi.org/10.1111/fcp.12856
Article CAS PubMed Google Scholar
Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Proper JL, Siegel LK, Klatt NR, Odde DJ, Luke DG, Anderson B, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Biros M, Sherwood NE, Thompson JL, Boulware DR, Murray TA, COVID-OUT Trial Team (2022) Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. N Engl J Med 387(7):599–610. https://doi.org/10.1056/nejmoa2201662
Article CAS PubMed PubMed Central Google Scholar
da Silva WAM, Guimarães ATB, Montalvão MF, Mendes BO, Rodrigues ASL, Malafaia G (2018) The chronic exposure to abamectin causes spatial memory deficit and depressive behavior in mice. Chemosphere 194:523–533. https://doi.org/10.1016/j.chemosphere.2017.12.028
Article CAS PubMed Google Scholar
Davis JA, Paylor R, McDonald MP, Libbey M, Ligler A, Bryant K, Crawley JN (1999) Behavioral effects of ivermectin in mice. Lab Anim Sci 49(3):288–296
Della-Morte D, Guadagni F, Palmirotta R, Testa G, Caso V, Paciaroni M, Abete P, Rengo F, Ferroni P, Sacco RL, Rundek T (2012) Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments. Pharmacogenomics 13(5):595–613. https://doi.org/10.2217/pgs.12.14
Article CAS PubMed Google Scholar
Denorme F, Portier I, Rustad JL, Cody MJ, de Araujo CV, Hoki C, Alexander MD, Grandhi R, Dyer MR, Neal MD, Majersik JJ, Yost CC, Campbell RA (2022) Neutrophil extracellular traps regulate ischemic stroke brain injury. J Clin Invest 16:132(10). https://doi.org/10.1172/jci154225
Doyle KP, Simon RP, Stenzel-Poore MP (2008) Mechanisms of ischemic brain damage. Neuropharmacology 55(3):310–318. https://doi.org/10.1016/j.neuropharm.2008.01.005
Article CAS PubMed PubMed Central Google Scholar
Durukan A, Tatlisumak T (2007) Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87(1):179–197. https://doi.org/10.1016/j.pbb.2007.04.015
Article CAS PubMed Google Scholar
Formiga FR, Leblanc R, de Souza Rebouças J, Farias LP, de Oliveira RN, Pena L (2021) Ivermectin: an award-winning drug with expected antiviral activity against COVID-19. J Control Release 329:758–761. https://doi.org/10.1016/j.jconrel.2020.10.009
Article CAS PubMed Google Scholar
Gaston LW, Brooks JE, Blumenthal HJ, Miller CE (1971) A study of blood coagulation following an acute stroke. Stroke 2(1):81–87. https://doi.org/10.1161/01.str.2.1.81
Article CAS PubMed Google Scholar
Gedar Totuk ÖM, Güzel ŞE, Ekici H, Kumandaş A, Emre Aydıngöz S, Yılmaz EÇ, Kırdan T, Midi A (2020) Effects of Algan Hemostatic Agent on bleeding time in a rat tail hemorrhage model. Ulus Travma Acil Cerrahi Derg 26(6):853–858. https://doi.org/10.14744/tjtes.2020.50384
George-Gay B, Parker K (2003) Understanding the complete blood count with differential. J Perianesth Nurs 18(2):96–117. https://doi.org/10.1053/jpan.2003.50013
Guo Q, Ma M, Yu H, Han Y, Zhang D (2023) Dexmedetomidine enables copper homeostasis in cerebral ischemia/reperfusion via ferredoxin 1. Ann Med 55(1):2209735. https://doi.org/10.1080/07853890.2023.2209735
Article CAS PubMed PubMed Central Google Scholar
Han SJ, Lovaszi M, Kim M, D’Agati V, Haskó G, Lee HT (2020) P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling. FASEB J 34(4):5465–5482. https://doi.org/10.1096/fj.201903287R
Article CAS PubMed Google Scholar
Heidary F, Gharebaghi R (2020) Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen. J Antibiot (Tokyo) 73(9):593–602. https://doi.org/10.1038/s41429-020-0336-z
Article CAS PubMed Google Scholar
Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR (2015) Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab 35(6):888–901. https://doi.org/10.1038/jcbfm.2015.45
Article CAS PubMed PubMed Central Google Scholar
Kamal AH, Tefferi A, Pruthi RK (2007) How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc 82(7):864–873. https://doi.org/10.4065/82.7.864
Article CAS PubMed Google Scholar
Kamat PK, Kalani A, Metreveli N, Tyagi SC, Tyagi N (2015) A possible molecular mechanism of hearing loss during cerebral ischemia in mice. Can J Physiol Pharmacol 93(7):505–516. https://doi.org/10.1139/cjpp-2014-0489
Article CAS PubMed PubMed Central Google Scholar
Karimipour M, Zarghani SS, Milani MM, Soraya H (2018) Pre-treatment with metformin in comparison with post-treatment reduces cerebral ischemia reperfusion induced injuries in rats. Bull Emerg Trauma 6(2):115. https://doi.org/10.29252/beat-060205
Article PubMed PubMed Central Google Scholar
Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7:97. https://doi.org/10.1186/1479-5876-7-97
Article CAS PubMed PubMed Central Google Scholar
Lee NT, Selan C, Chia JSJ, Sturgeon SA, Wright DK, Zamani A, Pereira M, Nandurkar HH, Sashindranath M (2020) Characterization of a novel model of global forebrain ischaemia-reperfusion injury in mice and comparison with focal ischaemic and haemorrhagic stroke. Sci Rep 10(1):18170. https://doi.org/10.1038/s41598-020-75034-4
Article CAS PubMed PubMed Central Google Scholar
Li G, Cao X, Liao J, Wei Y (2023) Pharmacokinetics of tenvermectin in swine, a novel antiparasitic drug candidate-comparison with ivermectin. Vet Med Sci 9(3):1211–1216. https://doi.org/10.1002/vms3.1085
Comments (0)